Skip to content

Efficacy of dialectical behavior therapy and anti-anxiety drugs on functional dyspepsia

Comparing the effectiveness of dialectical behavior therapy and anti-anxiety medication on anxiety and symptoms of patient with functional dyspepsia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171022036938N2
Enrollment
60
Registered
2018-04-16
Start date
2018-04-04
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention in the first intervention group:dialectical behavior therapy:an Interventional behavior therapy including discussion and practice in each meetings and also at home in orde
Made of 20 items,according to 6 degree classification 0 to 5 (no symptoms to very severe symptoms). Intervention 2: Intervention in the second intervention group: Anti-anxiety treatment: Sertraline, 1

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 50 years old Patients who accepted to participate in the study after explaining the purposes of the study and advantages and disadvantages of the interventions There should be the possibility to keep the type and dose of the medications fixed during the study Having at least diploma education

Exclusion criteria

Exclusion criteria: Patients who do have psychotic or other simultaneous digestive disorders Having full criteria of personality disorders Patients who do not have alarm signs including gastrointestinal bleeding, blood in stool, fever, weight loss, anemia, diarrhea at night, severe abdominal pain and so on

Design outcomes

Primary

MeasureTime frame
Functional dyspepsia severity. Timepoint: Before and right after the end of intervention. Method of measurement: Patient assessment of upper gastrointestinal symptom (PAGI-SYM) designed by Rentz in 2004; Made of 20 items,according to 6 degree classification 0 to 5 (no symptoms to very severe symptoms): no symptoms(0 to 20)- mild(21 to 40)- moderate(41 to 60)- sever(61 to 80)- very sever(81 to 100).

Secondary

MeasureTime frame
Anxiety severity. Timepoint: Before and right after the end of intervention. Method of measurement: Anxiety score from beck anxiety inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosseini Masoud

Birjand University of Medical Sciences

masoud60h@yahoo.com+98 51 3761 3026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026